Scientific News: A big acquisition decades ago almost broke Boston Scientific. Its CEO says this time is different.

Choose a language:

Science Daily Reports

Details: Written by Bing News Search Results; Category: Science Daily Reports; Published: 17 January 2026; Created: 17 January 2026; Last Updated: 17 January 2026

Boston Scientific’s last mega-deal didn’t go so well. The medtech company with a large Minnesota presence acquired Arden Hills’ Guidant for $27 billion in 2006. This triggered years of legal ...
Original Image Link
Source:www.msn.com

Posted: 2026-01-17 04:00:00

Get Full News Story On Bing Science News Network

Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.

More News From This Category
Scientific News: The next AI revolution could start with world models
Sat, 17 Jan 2026 14:07:16 +0000

Why today’s AI systems struggle with consistency, and how emerging world models aim to give machines a steady grasp of space and time ...
Original Image Link
Source:www.scientificamerican.com

Scientific News: Penumbra stock jumps. It’s being bought by Boston Scientific for $14.5 billion
Sat, 17 Jan 2026 08:07:13 +0000

Penumbra shares soared 12% to $351.46 on Thursday. Boston Scientific stock slumped 4.1%, making it one of the worst performers in the S&P 500. Boston Scientific was a Barron’s stock pick in October.
Original Image Link
Source:www.msn.com

Scientific News: Boston Scientific is buying Penumbra for $14.5 billion to get into the business of removing blood clots
Sat, 17 Jan 2026 05:07:15 +0000

Boston Scientific is spending $14.5 billion in cash and stock to buy Penumbra, another medical-device maker that makes products used in minimally invasive procedures to treat conditions such as blood ...
Original Image Link
Source:www.msn.com

Scientific News: Boston Scientific to buy Penumbra in $14.5 billion deal
Fri, 16 Jan 2026 05:07:14 +0000

Boston Scientific said on Thursday it will buy Penumbra in a deal valued at about $14.5 billion to expand its vascular pipeline. The deal values Penumbra at $374 per share, a premium of about 19.3% to ...
Original Image Link
Source:www.msn.com

Related Bing News Results
Scientists reverse Alzheimer’s in mice and restore memory
Wed, 24 Dec 2025 11:07:00 GMT
Alzheimer’s has long been considered irreversible, but new research challenges that assumption. Scientists discovered that severe drops in the brain’s energy supply help drive the disease—and ...